Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Accelerate Diagnostics Inc
0H8ECurrent price
1.54 USD
-0.2 USD (-11.41%)
Last closed
1.6 USD
Company
acceleratediagnostics.com
ISIN
US00430H1023
Sector
Healthcare
Industry
Medical Devices
Exchange
London Exchange
Capitalization
37 413 452 USD
Yield for 12 month
-74.65 %
1Y
3Y
5Y
10Y
15Y
0H8E
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona. Address: 3950 South Country Club Road, Tucson, AZ, United States, 85714
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.5 USDP/E ratio
–Dividend Yield
–Current Year
+12 059 000 USD
Last Year
+12 752 000 USD
Current Quarter
+2 986 000 USD
Last Quarter
+2 921 000 USD
Current Year
+2 550 000 USD
Last Year
+3 303 000 USD
Current Quarter
+676 000 USD
Last Quarter
+723 000 USD
Key Figures 0H8E
1 year
3 years
5 years
10 years
EBITDA
-40 770 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-75.85 %
PEG Ratio
-0.55
Return On Equity TTM
–
Wall Street Target Price
1.5 USD
Revenue TTM
12 233 000 USD
Book Value
-1.47 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.2 %
Dividend Yield
–
Gross Profit TTM
3 303 000 USD
Earnings per share
-1.35 USD
Diluted Eps TTM
-1.35 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 0H8E
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0H8E
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
12.07.2023
Dividend Date
–
Stock Valuation 0H8E
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.0189
Price Sales TTM
3.0584
Enterprise Value EBITDA
-1.0983
Price Book MRQ
–
Financials 0H8E
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0H8E
For 52 weeks
0.73 USD
7 USD
50 Day MA
1.44 USD
Shares Short Prior Month
599 302
200 Day MA
1.78 USD
Short Ratio
10.61
Shares Short
551 138
Short Percent
3.56 %
BeatStart